-
1 month ago | 
kevinmd.com | Blake Walker |Akshat Jain |Michael McGuire |Leonard Wang
Most provider groups are not optimized to manage patient billing, and it’s breaking the bank. The problem often starts with the EHR systems that they have adopted, which are designed with insurance reimbursement as the priority, not the patient experience in mind. For decades, providers operated in a world where the vast majority of their revenue came from insurance reimbursements. For most provider groups, patient billing was an afterthought.
-
1 month ago | 
pharmacytimes.com | Aislinn Antrim |Michael McGuire
CommentaryVideoMarch 7, 2025Author(s):,Michael McGuire, PharmD, highlights the importance of early intervention in hospital settings, leveraging manufacturer programs, and navigating complex dosing regimens. In an interview with Pharmacy Times, Michael McGuire, PharmD, delves into the crucial role pharmacists play in advocating for and implementing long-acting injectable (LAI) medications for individuals with schizophrenia.
-
1 month ago | 
kevinmd.com | Scott Abramson |Michael McGuire |Cindy Thompson |Michele Luckenbaugh
Perhaps almost as important as our history-taking, our diagnosis, and our care of patients are the words we use to communicate that history-taking, that diagnosis, and that care. Scenario one: the not so goodA while ago, I happened to witness a family hospital conference about their dad’s new diagnosis of cancer. There were ten family members present, all very devoted and concerned, though not particularly medically sophisticated.
-
1 month ago | 
pharmacytimes.com | Aislinn Antrim |Michael McGuire
CommentaryVideoMarch 3, 2025Author(s):,LAIs offer a variety of benefits, from improved medication adherence and relapse prevention to enhanced quality of life for individuals with schizophrenia. In an interview with Pharmacy Times, Michael McGuire, PharmD, a professor of pharmacy practice at the Belmont University College of Pharmacy and Health Sciences, delved into the increasingly important role of long-acting injectable (LAI) therapies in the management of schizophrenia.
-
1 month ago | 
pharmacytimes.com | Michael McGuire |Aislinn Antrim
CommentaryVideoFebruary 26, 2025Author(s):,Research has demonstrated a reduction in hospitalization risk associated with the use of LAIs, but some barriers can prevent the wider adoption of this approach.
-
2 months ago | 
kevinmd.com | Michael McGuire |Leonard Wang |Erin Paterson
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes!In this episode, psychiatrist Chika Oriuwa discusses her KevinMD article, “How a psychiatrist rebuilt trust with a patient in crisis.” She also reflects on her book Unlike the Rest: A Doctor’s Story, sharing an emotionally charged encounter with a patient in crisis. Chika explores the challenges of racial bias in psychiatry and the power of empathy in rebuilding trust.
-
Jan 13, 2025 | 
kevinmd.com | Allie Poles |Denise Reich |Michael McGuire |Leonard Wang
This article is sponsored by Stryker Oral Care. Hospital-acquired pneumonia remains one of the most common—and deadly—infections patients face during hospitalization. Yet, while significant progress has been made in reducing ventilator-associated pneumonia, its lesser-known counterpart, non-ventilator hospital-acquired pneumonia (NVHAP), continues to quietly harm patients, often escaping attention altogether.
-
Nov 26, 2024 | 
kevinmd.com | Diane W. Shannon |Michael McGuire |Advait Suvarnakar |Aashka Suvarnakar
Here’s something you may already know. I didn’t until recently, but I sure do now, and it’s a lesson I won’t forget—something I wish I’d known three weeks ago. Rabbits love cone flowers. We recently downsized to a cute house with window boxes. I’ve never had window boxes before and am honestly not much of a gardener. I went to the local place where we buy plants and picked out some tall red ones, some shorter purple ones, and even shorter yellow ones.
-
Nov 22, 2024 | 
kevinmd.com | David Stukus |Michael McGuire |Patricia McTiernan |Jim Sholler
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes!Join us for an enlightening conversation with Julia Hotz, journalist and author of The Connection Cure: The Prescriptive Power of Movement, Nature, Art, Service, and Belonging. We explore the transformative potential of social prescribing, a practice that shifts patient care from focusing solely on treatment to empowering holistic health and prevention.
-
Nov 21, 2024 | 
kevinmd.com | Akshat Jain |Michael McGuire |Leonard Wang |Erin Paterson
The withdrawal of Oxbryta (voxelotor) from global markets, announced by Pfizer after a recent data review revealed a rise in deaths and complications, has left sickle cell disease (SCD) patients in a precarious situation. The sudden nature of the announcement caught the patient and physician community off guard, as there was no prewarning. For an already narrow world of options available to people with sickle cell disease, this came as a devastating blow.
